Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: best news in the history of the company and management is going

lamberts, I agree with you.

Anyone can do estimating off the top of their head, but few seem to be taking the time to do some calculations based on past earnings per license, number of companies outrstanding, and then extrapolate to potential future earnings. Take into consideration the size of companies aready licensed vs yet to be licensed, and estimate the potential increased price for a license after winning the case. If you spreadsheet these numbers and add estimates of sales per year you can play with the variables to see what it would take to reach $10/share. My take is the assumptions have to get unrealistic to reach $10.

I'm holding but don't have such high hopes. We need a big jump in sales now to drive the price up. The court ruling is inconclusive and old news already.

Share
New Message
Please login to post a reply